Related Experiment Video
Updated: Oct 12, 2025
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
15.0K
Kinase Inhibitors' Effects on Innate Immunity in Solid Cancers
Chunying Peng1,2, Katrin Rabold1,2, Willem J M Mulder3,4
1Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Cancers
|November 27, 2021
Summary
Kinase inhibitors (KIs) show promise in cancer therapy by modulating innate immune cells within the tumor microenvironment. Further research is needed to optimize their immunomodulatory effects for enhanced immunotherapy.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Innate immune cells are key components of the tumor microenvironment.
- These cells are viable targets for cancer therapies like ablation or reprogramming.
- Kinase inhibitors (KIs) targeting tumor growth also impact myeloid cells, potentially aiding anti-tumor immunity.
Purpose of the Study:
- To evaluate the immunological effects of kinase inhibitors (KIs).
- To explore how KIs' immunomodulatory mechanisms can improve combined cancer treatment regimens.
- To identify optimal immunomodulatory effects of KIs for targeted immunotherapy.
Main Methods:
- Literature review and analysis of existing data on kinase inhibitors.
- Evaluation of immunological effects of KIs on myeloid cells.
- Assessment of potential applications in combined cancer therapy.
Main Results:
- Kinase inhibitors possess significant, yet poorly described, immunomodulatory effects on myeloid cells in cancer patients.
- These effects suggest a role in supporting anti-tumor immune responses.
- KIs are currently in clinical trials for solid cancers, highlighting their therapeutic potential.
Conclusions:
- Kinase inhibitors offer a dual approach to cancer treatment by targeting tumor growth and modulating the immune system.
- Harnessing the immunomodulatory effects of KIs can lead to more effective and targeted immunotherapies.
- Further research is crucial to fully understand and optimize KI-mediated immune modulation for improved cancer treatment outcomes.
Related Concept Videos
02:34Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
01:27Cytotoxic T Cells-mediated Immune Response
4.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.3K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:20The JAK-STAT Signaling Pathway
9.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.5K
01:28Cells of the Innate Immune Response
5.9K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
5.9K
02:50Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K